It has been proven as a result of clinical tests that a drug developed by the National Institutes of Health, which carries out studies within the US Department of Health and Social Services, provides at least 6 months protection against malaria.

According to the findings of the research published in the medical journal New England Journal of Medicine; A drug has been developed that provides temporary protection against malaria.

In a study conducted in Mali, one of the West African countries, it was determined that the drug developed against malaria provides at least 6 months protection in adults in a single use.

In the study involving 330 adult Malians, malaria-carrying subjects were followed for 24 weeks. Accordingly, the high-dose drug given to the subjects is 88 percent effective and the low-dose 75 percent effective.

The drug developed against malaria is planned to be used in seasonal seasons when the disease is common.

The first vaccine developed for malaria, which kills hundreds of thousands of people each year in many parts of the world, was launched in Malawi in April 2019.